News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Enzymotec Announces Publication Of Clinical Study Results On Crying Reduction Following Usage Of INFAT® In Infants


7/7/2014 8:22:59 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MIGDAL HA'EMEQ, Israel, July 7, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today on publication of its clinical study results evaluating the effect of INFATĀ® usage on crying in healthy infants (link to the journal: http://www.biomedcentral.com/1471-2431/14/152).

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
Enzymotec
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES